Home
Rosetta Genomics Ltd.

Rosetta Genomics Ltd. Market Share Analysis for February 2026

Health > Biotechnology and Pharmaceuticals

Domainrosettagx.com

Year Founded2000

Employees51 - 200

Annual Revenue$5M - $10M

Rosetta Genomics Ltd.

Rosetta Genomics Ltd. (including company regionals)

rosettagx.com

See more website traffic and engagement information

Rosetta Genomics Ltd. Revenue up to February 2026 is 5M - 10M

revenue generated by Rosetta Genomics Ltd. top domains

Rosetta Genomics Ltd. top domains revenue over 3 years

Revenue for Rosetta Genomics Ltd. top domains

rosettagx.com5M - 10M

See more with Sales Intelligence

Total visits to Rosetta Genomics Ltd.'s top domains

Understand Rosetta Genomics Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rosettagx.com599

See more with Sales Intelligence

Avg. visit duration in Rosetta Genomics Ltd.'s top domains

Analyze Rosetta Genomics Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Rosetta Genomics Ltd.'s top domains

See how Rosetta Genomics Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rosettagx.com1.06

See more with Sales Intelligence

Rosetta Genomics Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Rosetta Genomics Ltd.

These are the website technologies, by industry, used by Rosetta Genomics Ltd. top domains

Conversion & Analytics (4)

Google Analytics

Widget (4)

Twemoji

Mobile (2)

Meta Viewport

Payment & Currencies (2)

Pound Sterling

More Technologies

3

See all

News & Signals from Rosetta Genomics Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRosettagx launched OncoGxOne on May 1st '15.In May 2015, Rosetta Genomics Ltd. launched OncoGxOne, Admera Health’s next-generation sequencing (NGS) panel that detects a vast number of genetic alterations implicated in cancer, to provide clear, concise, and actionable clinical recommendations from a single, comprehensive test.

NewsGenoptix Inc. acquired Rosettagx for $10M on Dec 15th '17.CARLSBAD, CA / PHILADELPHIA, PA / REHOVOT, ISRAEL / ACCESSWIRE / December 15, 2017 / Genoptix, Inc., a leading oncology diagnostic laboratory, and Rosetta Genomics Ltd. ( ROSG ), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, jointly announce that they have entered into a definitive merger agreement under which Genoptix will acquire all of the outstanding shares of Rosetta Genomics for a total gross purchase price of $10 million.

NewsKen Berlin leaves Rosettagx as President and Chief Executive Officer.Joining me from Rosetta Genomics are Ken Berlin, President and Chief Executive Officer; and Ron Kalfus, Chief Financial Officer.